SEC Form 4 · accession 0001237899-16-000090
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Terifay
Officer — EVP Commercial
Period of report
Dec 16, 2016
Accepted (ET)
Dec 19, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $381.92 | Dec 16, 2016 | A | 34,000 | A | — | Dec 16, 2026 | Common Stock | 34,000 | 34,000 | D |
Explanation of responses
- F1The stock option award vests in four equal annual installments, commencing one year after the date of grant.